These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 21122624)

  • 1. HDL as a treatment target.
    Brown WV; Brewer HB; Rader DJ; Schaefer EJ
    J Clin Lipidol; 2010; 4(1):5-16. PubMed ID: 21122624
    [No Abstract]   [Full Text] [Related]  

  • 2. In vivo macrophage-specific RCT and antioxidant and antiinflammatory HDL activity measurements: New tools for predicting HDL atheroprotection.
    Escolà-Gil JC; Rotllan N; Julve J; Blanco-Vaca F
    Atherosclerosis; 2009 Oct; 206(2):321-7. PubMed ID: 19362310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of HDL and its modulators in the development of diabetes.
    Ng DS; Saw NM
    Curr Opin Lipidol; 2012 Apr; 23(2):167-8. PubMed ID: 22418575
    [No Abstract]   [Full Text] [Related]  

  • 4. Naturally occurring and bioengineered apoA-I mutations that inhibit the conversion of discoidal to spherical HDL: the abnormal HDL phenotypes can be corrected by treatment with LCAT.
    Koukos G; Chroni A; Duka A; Kardassis D; Zannis VI
    Biochem J; 2007 Aug; 406(1):167-74. PubMed ID: 17506726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ATP-binding cassette transporters G1 and G4 mediate cholesterol and desmosterol efflux to HDL and regulate sterol accumulation in the brain.
    Wang N; Yvan-Charvet L; Lütjohann D; Mulder M; Vanmierlo T; Kim TW; Tall AR
    FASEB J; 2008 Apr; 22(4):1073-82. PubMed ID: 18039927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ATP-binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high-density lipoproteins.
    Wang N; Lan D; Chen W; Matsuura F; Tall AR
    Proc Natl Acad Sci U S A; 2004 Jun; 101(26):9774-9. PubMed ID: 15210959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel therapies to increase apolipoprotein AI and HDL for the treatment of atherosclerosis.
    Wong NC
    Curr Opin Investig Drugs; 2007 Sep; 8(9):718-28. PubMed ID: 17729183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraretinal lipid transport is dependent on high density lipoprotein-like particles and class B scavenger receptors.
    Tserentsoodol N; Gordiyenko NV; Pascual I; Lee JW; Fliesler SJ; Rodriguez IR
    Mol Vis; 2006 Oct; 12():1319-33. PubMed ID: 17110915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma levels of 27-hydroxycholesterol in humans and mice with monogenic disturbances of high density lipoprotein metabolism.
    Karuna R; Holleboom AG; Motazacker MM; Kuivenhoven JA; Frikke-Schmidt R; Tybjaerg-Hansen A; Georgopoulos S; van Eck M; van Berkel TJ; von Eckardstein A; Rentsch KM
    Atherosclerosis; 2011 Feb; 214(2):448-55. PubMed ID: 21130455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HDL: the metabolism, function, and therapeutic importance.
    Wang M; Briggs MR
    Chem Rev; 2004 Jan; 104(1):119-37. PubMed ID: 14719972
    [No Abstract]   [Full Text] [Related]  

  • 11. Role of apoA-I, ABCA1, LCAT, and SR-BI in the biogenesis of HDL.
    Zannis VI; Chroni A; Krieger M
    J Mol Med (Berl); 2006 Apr; 84(4):276-94. PubMed ID: 16501936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statin-induced decrease in ATP-binding cassette transporter A1 expression via microRNA33 induction may counteract cholesterol efflux to high-density lipoprotein.
    Niesor EJ; Schwartz GG; Perez A; Stauffer A; Durrwell A; Bucklar-Suchankova G; Benghozi R; Abt M; Kallend D
    Cardiovasc Drugs Ther; 2015 Feb; 29(1):7-14. PubMed ID: 25749868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LCAT can rescue the abnormal phenotype produced by the natural ApoA-I mutations (Leu141Arg)Pisa and (Leu159Arg)FIN.
    Koukos G; Chroni A; Duka A; Kardassis D; Zannis VI
    Biochemistry; 2007 Sep; 46(37):10713-21. PubMed ID: 17711302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mouse models of disturbed HDL metabolism.
    Hoekstra M; Van Eck M
    Handb Exp Pharmacol; 2015; 224():301-36. PubMed ID: 25522993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HDL particle size is a critical determinant of ABCA1-mediated macrophage cellular cholesterol export.
    Du XM; Kim MJ; Hou L; Le Goff W; Chapman MJ; Van Eck M; Curtiss LK; Burnett JR; Cartland SP; Quinn CM; Kockx M; Kontush A; Rye KA; Kritharides L; Jessup W
    Circ Res; 2015 Mar; 116(7):1133-42. PubMed ID: 25589556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased cholesterol efflux capacity in metabolic syndrome: Relation with qualitative alterations in HDL and LCAT.
    Lucero D; Sviridov D; Freeman L; López GI; Fassio E; Remaley AT; Schreier L
    Atherosclerosis; 2015 Sep; 242(1):236-42. PubMed ID: 26232163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functionality of High-Density Lipoprotein as Antiatherosclerotic Therapeutic Target.
    Hoekstra M; Van Berkel TJ
    Arterioscler Thromb Vasc Biol; 2016 Nov; 36(11):e87-e94. PubMed ID: 27784702
    [No Abstract]   [Full Text] [Related]  

  • 18. The origin and metabolism of a nascent pre-β high density lipoprotein involved in cellular cholesterol efflux.
    Wróblewska M
    Acta Biochim Pol; 2011; 58(3):275-85. PubMed ID: 21750785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of cholesterol ester transfer protein inhibition on cholesterol efflux.
    Tall AR
    Am J Cardiol; 2009 Nov; 104(10 Suppl):39E-45E. PubMed ID: 19895943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association between lecithin-cholesterol acyltransferase activity and fatty liver index.
    Janac J; Zeljkovic A; Jelic-Ivanovic Z; Dimitrijevic-Sreckovic V; Miljkovic M; Stefanovic A; Munjas J; Vekic J; Kotur-Stevuljevic J; Spasojević-Kalimanovska V
    Ann Clin Biochem; 2019 Sep; 56(5):583-592. PubMed ID: 31084205
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.